Drug research

Atacicept

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as VT-001

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Monthly Dosing of Atacicept in IgANNCT07020923	VERA	Phase 2	Active not recruiting	2026-09Estimated
Atacicept in Multiple Glomerular DiseasesNCT06983028	VERA	Phase 2	Recruiting	2027-11Estimated
Atacicept in Subjects With IgA NephropathyNCT04716231	VERA	Phase 3	Active not recruiting	2025-05-15Actual

VERAActive not recruitingPrimary completion: 2026-09 · Estimated

Trial details

VERARecruitingPrimary completion: 2027-11 · Estimated

Trial details

VERAActive not recruitingPrimary completion: 2025-05-15 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.